Available in your pharmacy for CHF 24.90!

Reconval K1 in multiple sclerosis

The treatment of multiple sclerosis with injectable drugs (e.g. beta-interferons), can cause undesirable side effects at the injection site, causing pain, burning or redness. In some cases, it has also been observed a skin and tissue necrosis. In such cases, the drug dose is usually reduced to prevent these painful side effects.

However, it deteriorates the effectiveness of the therapy. With Reconval K1 these skin side effects can be alleviated.